COVID-19 Risk Factors
literature database & meta-analysis

Last update : 2020-08-06 21:54:31 (GMT+2)   |  276 factors investigated   |  1766 estimates included  |  219 articles processed  |  QC progress: 51%

Associated factors

Outcomes

Filters

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.
Green: significant protective factor
Red: significant risk factor
§ adjusted estimate (see article details)
estimated using data reported in the article
Outcome Risk category Risk [exposed vs. unexposed] Risk estimate (95% CI) Author [URL] View QC
SARS COV-2 infection Symptoms Fever [Present vs. Not present] Odds ratio: 2.400 (1.100-5.000) § Roland
SARS COV-2 infection Symptoms Shortness of breath [Present vs. Not present] Odds ratio: 0.200 (0.100-0.400) § Roland
SARS COV-2 infection Symptoms Smell or taste change [Present vs. Not present] Odds ratio: 6.800 (3.900-12.000) § Roland
Virus clearance Treatment Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received] Odds ratio: 2.370 (0.130-44.530) Sharma
COVID-19 (severe/fatal) Treatment Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received] Odds ratio: 1.370 (0.090-21.970) Sharma
COVID-19 (severe/critical) Treatment Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received] Odds ratio: 0.310 (0.110-0.900) Sharma
COVID-19 (survival) Complications Initial ECG rhythm [Asystole vs. VF/VT] Odds ratio: 0.010 (0.000-0.160) § Shao
COVID-19 (survival) Complications Initial ECG rhythm [PEA vs. VF/VT] Odds ratio: 0.140 (0.010-3.480) § Shao
COVID-19 (survival) Complications Aetiology of cardiac arrest [Other causes vs. Cardiac] Odds ratio: 0.640 (0.020-22.060) § Shao
COVID-19 (survival) Complications Aetiology of cardiac arrest [Respiratory causes vs. Cardiac] Odds ratio: 0.230 (0.020-2.470) § Shao
COVID-19 (survival) Other Witness at cardiac arrest occurence [Yes vs. No] Odds ratio: 0.250 (0.010-5.570) § Shao
COVID-19 (survival) Other Location of cardiac arrest occurrence [ICU vs. General ward] Odds ratio: 16.800 (1.663-169.700) § Shao
COVID-19 (survival) Patient characteristics Gender [Male vs. Female] Odds ratio: 4.280 (0.220-82.710) § Shao
COVID-19 (survival) Patient characteristics Age [>60 years vs. <=60 years] Odds ratio: 0.280 (0.020-4.090) § Shao
COVID-19 (severe/fatal) Treatment Concomitant medication [Treated with ACEi/ARB vs. Not received] Odds ratio: 1.320 (0.800-2.180) § Mehta
COVID-19 (severe/fatal) Treatment Concomitant medication [Treated with ARBs vs. Not received] Odds ratio: 1.120 (0.590-2.120) § Mehta
COVID-19 (severe/fatal) Treatment Concomitant medication [Treated with ACEi vs. Not received] Odds ratio: 1.350 (0.740-2.470) § Mehta
COVID-19 (severe/critical) Treatment Concomitant medication [Treated with ACEi/ARB vs. Not received] Odds ratio: 1.640 (1.070-2.510) § Mehta
COVID-19 (severe/critical) Treatment Concomitant medication [Treated with ARBs vs. Not received] Odds ratio: 1.160 (0.670-2.020) § Mehta
COVID-19 (severe/critical) Treatment Concomitant medication [Treated with ACEi vs. Not received] Odds ratio: 1.770 (1.070-2.920) § Mehta
COVID-19 (any condition) Treatment Concomitant medication [Treated with ACEi/ARB vs. Not received] Odds ratio: 1.930 (1.380-2.710) § Mehta
COVID-19 (any condition) Treatment Concomitant medication [Treated with ARBs vs. Not received] Odds ratio: 1.610 (1.040-2.500) § Mehta
COVID-19 (any condition) Treatment Concomitant medication [Treated with ACEi vs. Not received] Odds ratio: 1.840 (1.220-2.790) § Mehta
SARS COV-2 infection Treatment Concomitant medication [Treated with ACEi/ARB vs. Not received] Odds ratio: 0.970 (0.810-1.150) § Mehta
SARS COV-2 infection Treatment Concomitant medication [Treated with ARBs vs. Not received] Odds ratio: 1.090 (0.870-1.370) § Mehta
SARS COV-2 infection Treatment Concomitant medication [Treated with ACEi vs. Not received] Odds ratio: 0.890 (0.720-1.100) § Mehta
COVID-19 (severe/fatal) Comorbidities Lung Disease [Present vs. Not present] Odds ratio: 0.760 (0.200-2.860) § Kalligeros
COVID-19 (severe/fatal) Comorbidities Heart disease [Present vs. Not present] Odds ratio: 3.410 (1.050-11.060) § Kalligeros
COVID-19 (severe/fatal) Comorbidities Hypertension [Present vs. Not present] Odds ratio: 0.470 (0.130-1.660) § Kalligeros
COVID-19 (severe/fatal) Comorbidities Diabetes [Present vs. Not present] Odds ratio: 2.130 (0.730-6.220) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 9.990 (1.390-71.690) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 6.850 (1.050-44.820) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 3.700 (0.600-22.870) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics Gender [Male vs. Female] Odds ratio: 1.130 (0.320-3.400) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics Ethnicity [Hispanic vs. Non-Hispanic White] Odds ratio: 1.170 (0.360-3.820) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics Ethnicity [Non-Hispanic Black vs. Non-Hispanic White] Odds ratio: 1.830 (0.550-6.110) § Kalligeros
COVID-19 (severe/fatal) Patient characteristics Age [1 year increase vs. Not applicable] Odds ratio: 1.020 (0.980-1.060) § Kalligeros
COVID-19 (severe/critical) Comorbidities Lung Disease [Present vs. Not present] Odds ratio: 1.500 (0.470-4.820) § Kalligeros
COVID-19 (severe/critical) Comorbidities Heart disease [Present vs. Not present] Odds ratio: 1.520 (0.510-4.510) § Kalligeros
COVID-19 (severe/critical) Comorbidities Hypertension [Present vs. Not present] Odds ratio: 0.790 (0.270-2.280) § Kalligeros
COVID-19 (severe/critical) Comorbidities Diabetes [Present vs. Not present] Odds ratio: 1.910 (0.710-5.190) § Kalligeros
COVID-19 (severe/critical) Patient characteristics BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 5.390 (1.130-25.640) § Kalligeros
COVID-19 (severe/critical) Patient characteristics BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 2.650 (0.640-10.950) § Kalligeros
COVID-19 (severe/critical) Patient characteristics BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)] Odds ratio: 2.270 (0.590-8.830) § Kalligeros
COVID-19 (severe/critical) Patient characteristics Gender [Male vs. Female] Odds ratio: 2.400 (0.870-6.640) § Kalligeros
COVID-19 (severe/critical) Patient characteristics Ethnicity [Hispanic vs. Non-Hispanic White] Odds ratio: 0.560 (0.190-1.580) § Kalligeros
COVID-19 (severe/critical) Patient characteristics Ethnicity [Non-Hispanic Black vs. Non-Hispanic White] Odds ratio: 0.800 (0.260-2.450) § Kalligeros
COVID-19 (severe/critical) Patient characteristics Age [1 year increase vs. Not applicable] Odds ratio: 1.030 (1.000-1.070) § Kalligeros
SARS COV-2 infection Other Exposure-period with infected persons in households [0-1 day vs. >1 day] Odds ratio: 0.900 (0.610-1.330) § Li
SARS COV-2 infection Other Symptoms of infected persons in households [No cough vs. Cough] Odds ratio: 0.880 (0.470-1.640) § Li
If a relevant publication escaped our attention, please contact us.